Head-to-head · WeighScore
Ro vs Wellorithm
By GLP-1 ScorecardUpdated
Score comparison
Ro has the higher recorded score — 80.2/100 to 48.5/100.
Ro grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Ro is worth comparing for branded access and insurance help, but the membership price is only one part of the bill.
Before you choose
Ro does not publish a semaglutide price, so its Ro review sets out what it does disclose, while the Wellorithm review explains the conditions attached to Wellorithm's figure. The semaglutide cost page compares published rates across the field. Ask Ro for a written total before treating either one as the cheaper choice.
If neither one fits, Ro vs Wholesome Clinic and RxSpan MD vs Wellorithm compare each of them with another graded program, and the list of alternatives to Ro ranks the programs closest to Ro on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Ro | Wellorithm |
|---|---|---|
| WeighScore | 80.2/100 | 48.5/100 |
| Grade | B− | C |
| Site position | #37 | #501 |
| Semaglutide | Varies (branded medication plus separate membership) | $179 first payment; $299 ongoing for compounded injection. Pricing says monthly; terms say every 28 days. Initial consultation and shipping included; usable supply unconfirmed. |
| Tirzepatide | Varies (branded medication plus separate membership) | $279 first payment; $399 ongoing for compounded injection. Pricing says monthly; terms say every 28 days. Initial consultation and shipping included; usable supply unconfirmed. |
| Coverage | Multi-state | Advertises all 50 states plus D.C.; confirm the specific treatment, prescribing clinician and dispensing pharmacy for your location. |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Site position #37 · B−
Strengths
- Brand-name access + insurance support
- Oral options
- Current pricing separates membership from medication charges
What to consider
- Membership starts at $39 for the first month, then $74–149 per month depending on term; the $74 rate requires annual prepayment
- Medication is extra; the total depends on the selected drug and payment arrangement
- Membership cancellation requires at least 48 hours before renewal; paid membership fees are described as nonrefundable
Strengths
- Publishes first and ongoing compounded injection charges separately
- Advertises the same medication price across its listed weekly dose ranges
- Initial consultation and shipping included in injection plan cards
- Lists four branded options and a generic oral dissolving-tablet option; exact quote and prescription still needed
What to consider
- Pricing says monthly renewal, while terms say billing every 28 days
- Oral ingredient, strength, supply and price not specified in the public injection table
- Branded pages carry inconsistent three-month/500mg footnotes; insurance service and cash-only terms need reconciliation
- Treating Professional Entities and dispensing pharmacy unnamed in the reviewed policies
- Consultation fee retention on clinical rejection is not quantified; processed-payment refunds are restricted
Featured provider
Wellorithm
Factor scores not reassessed.Wellorithm scores 48.5/100 (C). Public first and ongoing injection prices, with unresolved monthly-versus-28-day billing and separately qualified oral and branded offers.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.